2024-03-29T09:18:15Z
http://repoint.unil.ch/oaiprovider/
oai:serval.unil.ch:BIB_083381A0D59E
2024-03-23T01:49:10Z
serval:BIB_083381A0D59E
Anti-leprosy drug clofazimine inhibits growth of triple-negative breast cancer cells via inhibition of canonical Wnt signaling.
10.1016/j.bcp.2013.12.007
24355563
000331430300005
Koval
A.V.
author
Vlasov
P.
author
Shichkova
P.
author
Khunderyakova
S.
author
Markov
Y.
author
Panchenko
J.
author
Volodina
A.
author
Kondrashov
F.A.
author
Katanaev
V.L.
author
article
2014
Biochemical Pharmacology
1873-2968
0006-2952
journal
87
4
571-578
Animals
Binding Sites/drug effects
Binding Sites/physiology
Cell Line, Tumor
Clofazimine/pharmacology
Clofazimine/therapeutic use
Crystallography, X-Ray
Growth Inhibitors/pharmacology
Growth Inhibitors/therapeutic use
HEK293 Cells
Humans
Leprostatic Agents/pharmacology
Leprostatic Agents/therapeutic use
Mice
Triple Negative Breast Neoplasms/chemistry
Triple Negative Breast Neoplasms/drug therapy
Wnt Signaling Pathway/drug effects
Wnt Signaling Pathway/physiology
Wnt3A Protein/antagonists & inhibitors
Wnt3A Protein/chemistry
eng
60_published
peer-reviewed
Publication types: Journal ArticlePublication Status: ppublish